RxDoctor Payments Data

Jessica Wilson, MD

Neurology · Chicago, ILNPI 1932696309

Payments from drug & device makers

$4,911in general payments, 2019–2025

Across 26 payments — averaging $188.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$4K
  • TG Therapeutics, Inc.$375
  • Genentech USA, Inc.$215
  • AstraZeneca$190
  • Amgen$153
  • Biogen$147
  • plus $191 from 3 others
$2,144in research payments, 2019–2025

Across 12 payments — averaging $178.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$2K

What the payments were for

  • Consulting fees$2,83858%
  • Food & beverage$1,99841%
  • Education$752%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi10$3,639
TG Therapeutics, Inc.4$375
Genentech USA, Inc.2$215
AstraZeneca3$190
Amgen(2 entities)2$153
Biogen1$147
EMD Serono, Inc.1$110
AbbVie2$55
Impel Pharmaceuticals Inc.1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,911 in reported general payments places this provider in the 70th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois

Medicare billing

Part B allowed, 2024
$2,836
Medicare patients
16
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Baclofen13$357

Paid to pharmacies, not to this prescriber.

Other neurology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →